Validea Peter Lynch Strategy Daily Upgrade Report

Validea upgraded a broad set of stocks in its P/E/Growth Investor model (Peter Lynch) after reassessing company fundamentals and valuations, with several names moving into the strategy’s interest range (80%+) and others showing modest score increases. Standouts include Acadia Healthcare (ACHC) rising from 0% to 91%, American Homes 4 Rent (AMH) to 91%, Enterprise Products Partners (EPD) to 91%, Ambev (ABEV) to 91%, Advanced Drainage Systems (WMS) to 87%, The New York Times (NYT) to 87% and ICF International (ICFI) to 91%, while firms such as MPLX, Limbach, NMI Holdings and Crawford saw smaller lifts into the mid-70s; the model flags pass/fail results across PEG, sales/P/E, debt ratios, EPS growth and cash flow for each name. For institutional investors and allocators this represents Validea’s signal set of idea-generation candidates where improved valuations or fundamentals meet Lynch-style P/E-to-growth and balance-sheet criteria, though several upgraded names still show mixed metrics (notably leverage or free-cash-flow scores) that warrant further due diligence.

Analysis

Validea’s P/E/Growth (Peter Lynch) model produced a broad set of upgrades across small-, mid- and large-cap names after reassessing fundamentals and valuations; notable score increases include Acadia Healthcare (ACHC) from 0% to 91%, American Homes 4 Rent (AMH) to 91%, Enterprise Products Partners (EPD) to 91%, Ambev (ABEV) to 91%, ICF International (ICFI) to 91%, Advanced Drainage Systems (WMS) to 87% and The New York Times (NYT) to 87%, while MPLX, Limbach and NMI Holdings moved modestly from ~72% to ~74%. The published thresholds (>=80% = strategy interest, >90% = strong interest) frame these upgrades as idea-generation signals rather than buy recommendations; the overall sentiment signal is mildly positive (0.25) with limited market-impact (0.15).

The model’s constituent tests show patterns: several high-scoring names pass PEG, EPS growth and debt metrics (for example AMH and EPD), while others exhibit red flags — Limbach fails EPS growth and MPLX and Veolia register debt/equity failures — and many stocks show neutral free-cash-flow or net-cash positions. These pass/fail flags are explicit in the report and vary by sector (REITs, midstream, healthcare, industrials), so sector-specific drivers matter for outlooks.

For investors this is a prioritized watchlist consistent with Lynch-style valuation-to-growth screening: names above 90% merit further diligence on reported cash flow, leverage and operational trends, candidates in the mid-70s reflect marginal improvements but material risks (leverage, weak EPS momentum) remain, and model upgrades should be validated against recent company filings and market price action before increasing exposure.

Key Decisions for Investors

• Treat stocks upgraded above 90% (ACHC, AMH, EPD, ABEV, ICF) as high-priority idea-generation targets and perform focused due diligence on recent earnings, free cash flow and guidance before initiating positions
• Avoid initiating sizable new exposure to names with debt/equity failures noted in the report (MPLX, Veolia) until leverage trajectories or refinancing risks are clarified, consider hedging or underweighting in energy/utilities allocations
• For mid-tier upgrades (scores ~80-89 such as WMS, NYT), consider selective accumulation on valuation dips but require confirmation of sustained EPS growth and normalized free cash flow
• Monitor Validea sentiment (mildly positive) and market-impact (low) signals and use these upgrades as screening inputs rather than standalone buy triggers, updating allocations only after company-level verification